Pfizer Raises $6 Billion in Bond Sale for Metsera Deal (3)

Pfizer Inc. sold $6 billion of US dollar bonds on Tuesday to help fund its acquisition of Metsera Inc.

The pharmaceutical company priced the bond offering across seven parts, according to a person with knowledge of the matter, who asked not to be identified discussing private details. The longest portion of the deal, a 40-year bond, yields 1 percentage point more than Treasuries, compared with initial price talk of about 1.25 percentage point, the person added.

The benchmark deal is the first US dollar offering from Pfizer in more than two years, according to Bloomberg-compiled data. The proceeds of ...